Company intelligence / Profile preview

Acceleris Capital

Manchester, England, United Kingdomacceleris.com ↗

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Acceleris Capital is a UK-based venture capital and corporate finance advisory firm specializing in early-stage technology SMEs addressing global unmet needs. The company has particular strength in the health care, biotechnology, and pharmaceutical sectors. It provides fundraising support for startups—especially those past MVP stage—and has helped portfolio companies such as BiVictriX Therapeutics reach significant milestones including IPOs on the London Stock Exchange’s AIM market. The group operates under FCA regulation and leverages deep networks across VC/angel investors to maximize funding opportunities for innovative startups.

Industry: Investors

Partnerships

Works closely with KPMG for branded advisory services ("KPMG Acceleris")

Beyond the preview

Go deeper on Acceleris Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acceleris Capital.

Explore the full profile